Ilika Plc Director Professor Sir William Wakeham Retires

Ilika plc

Ilika plc (LON:IKA), the advanced solid-state battery technology and materials innovation company, announced today that with effect from 30 September 2018, Professor Sir William Wakeham will be retiring from the board of the Company as a Non-Executive Director. Professor Sir William was appointed to the Board in May 2010 when the Company completed its IPO and he retires in line with the Company’s best practice governance guidelines.

Professor Sir William’s place on the board, the nomination, audit and remuneration committees will be filled by Jeremy Millard who is expected to be joining the board on 1 October and will be offering himself for election at the forthcoming AGM on 4 October 2018.

Jeremy has nearly 20 years investment banking experience and was previously a partner at Smith Square Partners LLC where he provided strategic and corporate advice to clients in the science, technology and telecommunications sectors, prior to which he headed up the technology practice at Rothschild in London. Jeremy is currently a Non-Executive Director and chairman of the audit committee of AIM-listed Idox plc as well as a Non-Executive Director of Blackbullion Limited.

Jeremy will be formally appointed to the Board following satisfactory completion of the customary due diligence for an AIM listed company’s board appointments. A further announcement confirming his appointment will be made once this process is completed and will include the disclosures required under Schedule 2(g) of the AIM Rules for Companies.

Mike Inglis, Chairman of Ilika Plc said: “The board would like to thank Bill for his service and the contribution he has made to the Company’s development during the past eight years. Bill’s technical and engineering experience has been key to the Company progressing the Stereax® battery technology.

“I would also like to welcome Jeremy to the board and expect to put his wealth of strategic advisory and corporate governance experience to good use in helping to develop Ilika as a business.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search